Delivery Order SPE2DB22D1002-SPE2DB24FKYS5
Award Date 3/1/24
Potential Completion Date 3/4/24
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $2,554.35 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TROKENDI XR 100 MG CAPSULE 30S, a prescription medication, with a performance period ending on May 30, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TROKENDI XR 200 MG CAPSULE 30S. The contract has a firm fixed price of $2,311.17 and a period of performance through July 9, 2025. This is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TROKENDI XR 100 MG CAPSULE 30S, a neurological medication, with a ceiling value of $4,648.71 and a period of performance through May 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of TROKENDI XR 200 MG CAPSULE 30S, a pharmaceutical product. The potential value of this delivery order is $2,113.64 and the period of performance is through January 26, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,064.50 firm fixed-price delivery order is for the supply of 4566177898 TROKENDI XR 100 MG CAPSULE 30S, with an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a $1,113.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TROKENDI XR 25 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This federal contract award is for the delivery of TROKENDI XR 100 MG CAPSULE 30S to the Defense Logistics Agency (DLA). The $2,283.05 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 12, 2024 and was awarded on June 11, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a $1,593.33 delivery order to AmerisourceBergen Drug Corp for TROKENDI XR 50 mg capsules (30-count) on December 3, 2025, with completion due by December 4, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- This federal contract award, with an ID of SPE2DB20D3505|SPE2DB25FT7E4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,965.33, is a delivery order for the supply of TROKENDI XR 200 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 3, 2025. It is not designated under any set-aside...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,436.67, is for the supply of Trokendi XR 100 mg capsules to support military healthcare programs. The contract has an ultimate completion date of March 24, 2025 and was awarded on March 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...